Page last updated: 2024-11-03

ro 31-8220 and Chronic Disease

ro 31-8220 has been researched along with Chronic Disease in 2 studies

Ro 31-8220: a protein kinase C inhibitor

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Das, M1
Dempsey, EC1
Bouchey, D1
Reyland, ME1
Stenmark, KR1
Webster, NJ1
Vaughan, PF1
Peers, C1

Other Studies

2 other studies available for ro 31-8220 and Chronic Disease

ArticleYear
Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes.
    American journal of respiratory cell and molecular biology, 2000, Volume: 22, Issue:1

    Topics: Animals; Animals, Newborn; Cattle; Cell Division; Cells, Cultured; Chronic Disease; Enzyme Inhibitor

2000
Hypoxic enhancement of evoked noradrenaline release from the human neuroblastoma SH-SY5Y.
    Brain research. Molecular brain research, 2001, Apr-18, Volume: 89, Issue:1-2

    Topics: Calcium; Cell Hypoxia; Chronic Disease; Electric Stimulation; Enzyme Inhibitors; Exocytosis; Humans;

2001